Associated Papers
Utilizing TP53 hotspot mutations as effective predictors of gemcitabine treatment outcome in non-small-cell lung cancer.
Tseng YH et al.
Cell Death Discovery, 2025
39870629 (PubMed )
Supplement: 41420_2025_2300_MOESM2_ESM.xlsx › Supplement_table_2
New insights into the clinical characteristics of SETD2-mutated acute myeloid leukaemia.
Zhang X et al.
British Journal of Haematology, 2023
Select a paper to view details